Retroperitoneal dedifferentiated liposarcoma lacking MDM2 amplification in a patient with a germ line CHEK2 mutation

[1]  M. King,et al.  Response to DNA damage of CHEK2 missense mutations in familial breast cancer. , 2012, Human molecular genetics.

[2]  M. Olivier,et al.  Sarcomas in TP53 germline mutation carriers , 2012, Cancer.

[3]  J. Bartek,et al.  Two new CHEK2 germ-line variants detected in breast cancer/sarcoma families negative for BRCA1, BRCA2, and TP53 gene mutations , 2011, Breast Cancer Research and Treatment.

[4]  S. Pai,et al.  p53+/mdm2− Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma in Young Children: An Early Expression of Li-Fraumeni Syndrome , 2010, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[5]  J. Bartek,et al.  The DNA-damage response in human biology and disease , 2009, Nature.

[6]  M. Garrett,et al.  CHK2 kinase: cancer susceptibility and cancer therapy – two sides of the same coin? , 2007, Nature Reviews Cancer.

[7]  T. Walsh,et al.  Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. , 2006, JAMA.

[8]  R. Eeles,et al.  Increasing evidence that germline mutations in CHEK2 do not cause Li‐Fraumeni syndrome , 2002, Human mutation.

[9]  T. Halazonetis,et al.  Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. , 2000, Genes & development.

[10]  K. Isselbacher,et al.  Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. , 1999, Science.

[11]  F. Rilke,et al.  Molecular abnormalities in liposarcoma: role of MDM2 and CDK4‐containing amplicons at 12q13–22 , 1998, The Journal of pathology.

[12]  F. Rilke,et al.  DISTINCT mdm2/p53 EXPRESSION PATTERNS IN LIPOSARCOMA SUBGROUPS: IMPLICATIONS FOR DIFFERENT PATHOGENETIC MECHANISMS , 1997, The Journal of pathology.

[13]  P. Cin,et al.  Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors. , 1993, Cancer genetics and cytogenetics.

[14]  H. Lynch,et al.  Genetic and pathologic findings in a kindred with hereditary sarcoma breast cancer, brain tumors, leukemia, lung, laryngeal, and adrenal cortical carcinoma , 1978, Cancer.

[15]  R. Schneider-Stock,et al.  MDM2 amplification and loss of heterozygosity at Rb and p53 genes: no simultaneous alterations in the oncogenesis of liposarcomas , 1998, Journal of Cancer Research and Clinical Oncology.

[16]  R. Schneider-Stock,et al.  On telomere shortening in soft-tissue tumors , 1998, Journal of Cancer Research and Clinical Oncology.